QQQ   430.82 (-0.06%)
AAPL   169.07 (-2.10%)
MSFT   415.14 (+0.36%)
META   500.34 (+0.02%)
GOOGL   154.59 (-0.17%)
AMZN   183.27 (-0.19%)
TSLA   156.07 (-3.35%)
NVDA   873.26 (+1.54%)
AMD   162.84 (+1.57%)
NIO   3.86 (-0.77%)
BABA   69.92 (-0.99%)
T   15.98 (-1.60%)
F   12.12 (-0.90%)
MU   121.02 (-0.29%)
GE   155.42 (+1.12%)
CGC   6.80 (-2.58%)
DIS   113.68 (+0.65%)
AMC   2.80 (+13.36%)
PFE   25.74 (-0.66%)
PYPL   63.57 (+0.09%)
XOM   118.23 (-1.21%)
QQQ   430.82 (-0.06%)
AAPL   169.07 (-2.10%)
MSFT   415.14 (+0.36%)
META   500.34 (+0.02%)
GOOGL   154.59 (-0.17%)
AMZN   183.27 (-0.19%)
TSLA   156.07 (-3.35%)
NVDA   873.26 (+1.54%)
AMD   162.84 (+1.57%)
NIO   3.86 (-0.77%)
BABA   69.92 (-0.99%)
T   15.98 (-1.60%)
F   12.12 (-0.90%)
MU   121.02 (-0.29%)
GE   155.42 (+1.12%)
CGC   6.80 (-2.58%)
DIS   113.68 (+0.65%)
AMC   2.80 (+13.36%)
PFE   25.74 (-0.66%)
PYPL   63.57 (+0.09%)
XOM   118.23 (-1.21%)
QQQ   430.82 (-0.06%)
AAPL   169.07 (-2.10%)
MSFT   415.14 (+0.36%)
META   500.34 (+0.02%)
GOOGL   154.59 (-0.17%)
AMZN   183.27 (-0.19%)
TSLA   156.07 (-3.35%)
NVDA   873.26 (+1.54%)
AMD   162.84 (+1.57%)
NIO   3.86 (-0.77%)
BABA   69.92 (-0.99%)
T   15.98 (-1.60%)
F   12.12 (-0.90%)
MU   121.02 (-0.29%)
GE   155.42 (+1.12%)
CGC   6.80 (-2.58%)
DIS   113.68 (+0.65%)
AMC   2.80 (+13.36%)
PFE   25.74 (-0.66%)
PYPL   63.57 (+0.09%)
XOM   118.23 (-1.21%)
QQQ   430.82 (-0.06%)
AAPL   169.07 (-2.10%)
MSFT   415.14 (+0.36%)
META   500.34 (+0.02%)
GOOGL   154.59 (-0.17%)
AMZN   183.27 (-0.19%)
TSLA   156.07 (-3.35%)
NVDA   873.26 (+1.54%)
AMD   162.84 (+1.57%)
NIO   3.86 (-0.77%)
BABA   69.92 (-0.99%)
T   15.98 (-1.60%)
F   12.12 (-0.90%)
MU   121.02 (-0.29%)
GE   155.42 (+1.12%)
CGC   6.80 (-2.58%)
DIS   113.68 (+0.65%)
AMC   2.80 (+13.36%)
PFE   25.74 (-0.66%)
PYPL   63.57 (+0.09%)
XOM   118.23 (-1.21%)
Free Trial

Neurocrine Biosciences (NBIX) Earnings Date, Estimates & Call Transcripts

→ Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad)
Free nbix Stock Alerts
$134.10
+2.36 (+1.79%)
(As of 02:20 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 1
Before Market Opens
Confirmed
Actual EPS
(Feb. 7)
$1.44 Beat By $0.31
Consensus EPS
(Feb. 7)
$1.13
Read Call Transcript
Listen to Call
Latest SEC 10-Q Filing
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

NBIX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NBIX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Neurocrine Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244$0.67$1.09$0.94 
Q2 20244$1.14$1.27$1.21 
Q3 20244$1.18$1.49$1.39 
Q4 20243$1.46$1.96$1.66 
FY 202415$4.45$5.81 $5.18

NBIX Earnings Date and Information

Neurocrine Biosciences last posted its quarterly earnings results on February 7th, 2024. The reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.13 by $0.31. The company earned $515.20 million during the quarter, compared to analyst estimates of $518.52 million. Its quarterly revenue was up 25.0% on a year-over-year basis. Neurocrine Biosciences has generated $2.42 earnings per share over the last year ($2.42 diluted earnings per share) and currently has a price-to-earnings ratio of 55.7. Earnings for Neurocrine Biosciences are expected to grow by 28.72% in the coming year, from $4.84 to $6.23 per share. Neurocrine Biosciences has confirmed that its next quarterly earnings report will be published on Wednesday, May 1st, 2024. Neurocrine Biosciences will be holding an earnings conference call on Wednesday, May 1st at 8:00 AM Eastern. Interested parties can register for or listen to the call..

Neurocrine Biosciences Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2024
Confirmed)		-------  
2/7/2024Q4 2023$1.13$1.44+$0.31$1.44$518.52 million$515.20 million      
10/31/2023Q3 2023$0.91$0.82($0.09)$0.82$479.09 million$498.80 million      
8/1/2023Q2 2023$0.77$0.95+$0.18$0.95$448.29 million$452.70 million
5/3/2023Q1 2023$0.26($0.79)($1.05)($0.79)$412.96 million$420.40 million
2/6/2023Q4 2022$1.15$1.24+$0.09$0.88$408.96 million$412.00 million    
11/1/2022Q3 2022$0.84$0.69($0.15)$0.69$378.05 million$387.90 million
8/4/2022Q2 2022$0.56($0.18)($0.74)($0.18)$340.62 million$378.20 million
5/4/2022Q1 2022$0.33$0.14($0.19)$0.14$304.07 million$310.60 million      
2/11/2022Q4 2021$0.61($0.08)($0.69)($0.08)$317.72 million$312.00 million    
11/1/2021Q3 2021$0.51$0.23($0.28)$0.23$297.02 million$296.00 million    
8/2/2021Q2 2021$0.52$0.43($0.09)$0.43$274.47 million$288.90 million    
5/4/2021Q1 2021$0.47$0.33($0.14)$0.33$247.81 million$236.60 million    

Neurocrine Biosciences Earnings - Frequently Asked Questions

When is Neurocrine Biosciences's earnings date?

Neurocrine Biosciences has confirmed that its next quarterly earnings data will be published on Wednesday, May 1st, 2024. Learn more on NBIX's earnings history.

Did Neurocrine Biosciences beat their earnings estimates last quarter?

In the previous quarter, Neurocrine Biosciences (NASDAQ:NBIX) reported $1.44 earnings per share (EPS) to beat the analysts' consensus estimate of $1.13 by $0.31. Learn more on analysts' earnings estimate vs. NBIX's actual earnings.

How can I listen to Neurocrine Biosciences's earnings conference call?

The conference call for Neurocrine Biosciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Neurocrine Biosciences's conference call transcript?

The conference call transcript for Neurocrine Biosciences's latest earnings report can be read online. Read Transcript

How can I view Neurocrine Biosciences's earnings report?

Neurocrine Biosciences's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Neurocrine Biosciences generate each year?

Neurocrine Biosciences (NASDAQ:NBIX) has a recorded annual revenue of $1.89 billion.

How much profit does Neurocrine Biosciences generate each year?

Neurocrine Biosciences (NASDAQ:NBIX) has a recorded net income of $249.70 million. NBIX has generated $2.42 earnings per share over the last four quarters.

What is Neurocrine Biosciences's price-to-earnings ratio?

Neurocrine Biosciences (NASDAQ:NBIX) has a trailing price-to-earnings ratio of 55.72 and a forward price-to-earnings ratio of 27.86.

What is Neurocrine Biosciences's EPS forecast for next year?

Neurocrine Biosciences's earnings are expected to grow from $4.84 per share to $6.23 per share in the next year, which is a 28.72% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:NBIX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Can't believe it's happening again
Manward Press
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The “Perfect Storm” for Gold
Gold Safe Exchange
Top 5 AI Stocks to Buy for 2024
Market Moving Trends